Stock Events

Stock Events

Scancell Hldgs 

$0.135200
24
-$0.00-0.59% 15:57 Today

Statistics

Day High
0.1235
Day Low
0.1235
52W High
0.3349
52W Low
0.1191
Volume
5,000
Avg. Volume
5,525
Mkt Cap
140.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23OctExpected
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-1.4
-1.03
-0.66
-0.3
Expected EPS
N/A
Actual EPS
N/A

Financials

-252.02%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
6.28MRevenue
-15.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCNLF. It's not an investment recommendation.
Lloyds Banking Group
7
LLOY.LSE
Legal & General Group
6
LGEN.LSE
Rolls-Royce
6
RR.LSE
Standard Life
6
SDLF.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap27.09B
Moderna is a leader in mRNA technology, similar to Scancell's focus on novel immunotherapies, making them direct competitors in the vaccine and therapeutic space.
BioNTech
BNTX
Mkt Cap23.14B
BioNTech competes in the development of novel immunotherapies for cancer and infectious diseases, directly aligning with Scancell's research focus.
Novavax
NVAX
Mkt Cap1.53B
Novavax is involved in the development of vaccines for infectious diseases, competing with Scancell's infectious disease vaccine programs.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a biopharmaceutical company that develops drugs for infectious diseases, directly competing with Scancell's therapeutic development.
AMGEN
AMGN
Mkt Cap196.12B
Amgen focuses on human therapeutics, including treatments for cancer and inflammation, overlapping with Scancell's therapeutic areas.
Pfizer
PFE
Mkt Cap137.76B
Pfizer develops vaccines and therapeutics for various diseases, competing with Scancell in the broader pharmaceutical and biotech industry.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of vaccines and therapeutics, similar to Scancell's focus areas.
Astrazeneca
AZN
Mkt Cap251.1B
AstraZeneca is involved in the development of vaccines and cancer treatments, making it a competitor in Scancell's key research areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals focuses on developing monoclonal antibodies, a technology that competes with Scancell's immunotherapy approaches.
Merck
MRK
Mkt Cap305.12B
Merck & Co. develops vaccines and cancer immunotherapies, directly competing with Scancell's product development pipeline.

About

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
Show more...
CEO
Dr. Phillip John L'Huillier MBA, Ph.D.
Employees
61
Country
United Kingdom
ISIN
GB00B63D3314
WKN
000A1JZ3D

Listings

LSE
GB
SCLP.LSE
OTC Link
US
SCNLF
F
DE
SCP.F

0 Comments

Share your thoughts

FAQ

What is Scancell Hldgs stock price today?▼
The current price of SCNLF is $0.14 USD — it has decreased by -0.59% in the past 24 hours. Watch Scancell Hldgs stock price performance more closely on the chart.
What is Scancell Hldgs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Scancell Hldgs stocks are traded under the ticker SCNLF.
What is Scancell Hldgs market cap?▼
Today Scancell Hldgs has the market capitalization of 140.31M
When is the next Scancell Hldgs earnings date?▼
Scancell Hldgs is going to release the next earnings report on October 23, 2026.
What were Scancell Hldgs earnings last quarter?▼
SCNLF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Scancell Hldgs revenue for the last year?▼
Scancell Hldgs revenue for the last year amounts to 6.28M USD.
What is Scancell Hldgs net income for the last year?▼
SCNLF net income for the last year is -15.82M USD.
How many employees does Scancell Hldgs have?▼
As of August 13, 2026, the company has 61 employees.
In which sector is Scancell Hldgs located?▼
Scancell Hldgs operates in the Health & Wellness sector.
When did Scancell Hldgs complete a stock split?▼
The last stock split for Scancell Hldgs was on July 26, 2011 with a ratio of 10:1.
Where is Scancell Hldgs headquartered?▼
Scancell Hldgs is headquartered in Oxford, United Kingdom.